Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C

European Respiratory Journal

Volumn 17, Issue 6, 2001, Pages 1195-1200

  Massie, R J H ^a   Poplawski, N ^a   Wilcken, B ^a   Goldblatt, J ^a   Byrnes, C ^a   Robertson, C ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Cystic fibrosis; Genotype; Phenotype; R117H

Indexed keywords

CHLORIDE; ELECTROLYTE; THYMIDINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; AGE; ARTICLE; ASIA; AUSTRALIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; DEATH; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; INFORMATION PROCESSING; INTRON; LUNG FUNCTION; MALE; MICROBIOLOGY; NEW ZEALAND; NEWBORN SCREENING; NUCLEOTIDE SEQUENCE; OUTPATIENT DEPARTMENT; PANCREAS; PANCREAS INSUFFICIENCY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIBLING; SPUTUM ANALYSIS; STATISTICAL ANALYSIS; SWEAT TEST; SYMPTOM;

ADOLESCENT; ADULT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENOTYPE; HUMANS; INFANT; INTRONS; MALE; MUTATION; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PHENOTYPE; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0034894085     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.00057001     Document Type: Article

References (20)

1. Genotype-phenotype correlations in cystic fibrosis
2. Correlation between genotype and phenotype in patients with cystic fibrosis
3. Mutations in CFTR associated with mild disease form Cl channels with altered pore properties
4. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
5. A mutation in CFTR produces different phenotypes depending on chromosomal background
6. Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium
7. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
8. For the Cystic Fibrosis Foundation Consensus Panel. The diagnosis of cystic fibrosis: A consensus statement
9. Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients
10. Cystic fibrosis transmembrane conductance regulator (CFTR) gene in allergic bronchopulmonary aspergillosis
11. Clinical features of cystic fibrosis patients with rare genotypes in Saguenay Lac-Saint-Jean (Quebec, Canada)
12. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: Four years experience
13. Pancreatic function and extended mutation analysis in ΔF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels
14. Identification of the cystic fibrosis gene: Genetic analysis
15. Development, multiplexing and application or ARMS tests for common mutations in the CFTR gene
16. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
17. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilising pilocarpine by iontophoresis
18. Rapid characterisation of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: Association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease
19. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphisms as a disease mutation
20. Pitfalls in the use of genotype analysis as the sole diagnostic criterion for cystic fibrosis